Achaogen Announces Closing of Initial Public Offering and Exercise of Underwriters' Over

SOUTH SAN FRANCISCO, Mar 17, 2014 (GLOBE NEWSWIRE via COMTEX) — Achaogen, Inc. (NASDAQ:AKAO) , a clinical-stage biopharmaceutical